These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 10793431)
1. Safety and tolerability of an aggressive tilt table test protocol in the evaluation of patients with suspected neurocardiogenic syncope. Vlay SC; Brodsky C; Vlay LC Pacing Clin Electrophysiol; 2000 Apr; 23(4 Pt 1):441-5. PubMed ID: 10793431 [TBL] [Abstract][Full Text] [Related]
2. Tilt testing in neurocardiogenic syncope: isosorbide versus isoproterenol. Hermosillo AG; Marquez MF; Jauregui-Renaud K; Falcon JC; Casanova JM; Guevara M; Cardenas M Acta Cardiol; 2000 Dec; 55(6):351-5. PubMed ID: 11227835 [TBL] [Abstract][Full Text] [Related]
3. Response to beta blockers in patients with neurocardiogenic syncope: how to predict beneficial effects. Natale A; Newby KH; Dhala A; Akhtar M; Sra J J Cardiovasc Electrophysiol; 1996 Dec; 7(12):1154-8. PubMed ID: 8985804 [TBL] [Abstract][Full Text] [Related]
4. Tilt table testing of young adult patients: improved speed and sensitivity using an isoproterenol bolus and a continuous 60 degrees tilt. Van de Walle JP; Panagides D; Messier M; Iovescu D; Fourcade L; Bory M; Touze JE Pacing Clin Electrophysiol; 1998 Mar; 21(3):494-8. PubMed ID: 9558678 [TBL] [Abstract][Full Text] [Related]
5. Head-up tilt test in patients with high pretest likelihood of neurally mediated syncope: an approximation to the "real sensitivity" of this testing. Pérez-Paredes M; Picó-Aracil F; Florenciano R; Sánchez-Villanueva JG; Ruiz Ros JA; Ruipérez JA Pacing Clin Electrophysiol; 1999 Aug; 22(8):1173-8. PubMed ID: 10461293 [TBL] [Abstract][Full Text] [Related]
6. Neurohormonal profile before and after beta-blockade in patients with neurocardiogenic syncope. Roul G; Riehl-Aleil V; Germain P; Bareiss P Pacing Clin Electrophysiol; 1999 Jul; 22(7):1020-30. PubMed ID: 10456630 [TBL] [Abstract][Full Text] [Related]
7. Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome. Theodorakis GN; Markianos M; Zarvalis E; Livanis EG; Flevari P; Kremastinos DT J Am Coll Cardiol; 2000 Jul; 36(1):174-8. PubMed ID: 10898430 [TBL] [Abstract][Full Text] [Related]
8. Predictors of positive head-up tilt test in patients with suspected neurocardiogenic syncope or presyncope. Oh JH; Kim JS; Kwon HC; Hong KP; Park JE; Seo JD; Lee WR Pacing Clin Electrophysiol; 2003 Feb; 26(2 Pt 1):593-8. PubMed ID: 12710319 [TBL] [Abstract][Full Text] [Related]
9. Distinct hemodynamic profiles in patients with vasovagal syncope: a heterogeneous population. Shen WK; Low PA; Rea RF; Lohse CM; Hodge DO; Hammill SC J Am Coll Cardiol; 2000 May; 35(6):1470-7. PubMed ID: 10807449 [TBL] [Abstract][Full Text] [Related]
10. Head-up tilt table testing in syncope: safety and efficiency of isosorbide versus isoproterenol in pediatric population. Swissa M; Epstein M; Paz O; Shimoni S; Caspi A Am Heart J; 2008 Sep; 156(3):477-82. PubMed ID: 18760129 [TBL] [Abstract][Full Text] [Related]
11. Application of head-up tilt table testing in children. Lai WT; Chen MR; Lin SM; Hwang HK J Formos Med Assoc; 2010 Sep; 109(9):641-6. PubMed ID: 20863991 [TBL] [Abstract][Full Text] [Related]
12. Reproducibility of nitrate-stimulated tilt testing in patients with suspected vasovagal syncope and a healthy control group. Aerts AJ; Dendale P; Block P; Dassen WR Am Heart J; 2005 Aug; 150(2):251-6. PubMed ID: 16086926 [TBL] [Abstract][Full Text] [Related]
13. [Sensitization of tilt-table testing for syncope of unknown etiology: which drug to use?]. Salamé E; Neemtallah R; Azar R; Antonios S; Jazra C; Kassab R Ann Cardiol Angeiol (Paris); 2006 Jun; 55(3):135-9. PubMed ID: 16792028 [TBL] [Abstract][Full Text] [Related]
14. Impedance cardiography: a role in vasovagal syncope diagnosis? Parry SW; Norton M; Pairman J; Baptist M; Wilton K; Reeve P; Sutcliffe K; Newton JL Age Ageing; 2009 Nov; 38(6):718-23. PubMed ID: 19749201 [TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of high-dose or low-dose isoproterenol upright tilt protocol for unexplained syncope in young adults. Carlioz R; Graux P; Haye J; Letourneau T; Guyomar Y; Hubert E; Bodart JC; Lequeuche B; Burlaton JP Am Heart J; 1997 Mar; 133(3):346-52. PubMed ID: 9060805 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of intravenous metoprolol during positive isoproterenol tilt-table test in the choice of treatment for neurocardiogenic syncope. Baran I; Gemici K; Ozdemir B; Saraç M; Güllülü S; Aydinlar A; Cordan J Indian Heart J; 2003; 55(1):40-3. PubMed ID: 12760586 [TBL] [Abstract][Full Text] [Related]
17. Head-up tilt table testing with low dose sublingual isosorbide dinitrate in the evaluation of unexplained syncope: a comparison with isoproterenol infusion. Aslan O; Guneri S; Badak O; Kirimli O; Goldeli O; Keskin V; Akdeniz B; Tekin U Can J Cardiol; 2002 Aug; 18(8):853-9. PubMed ID: 12215748 [TBL] [Abstract][Full Text] [Related]
18. Head-upright tilt table testing. A safe and easy way to assess neurocardiogenic syncope. Grubb BP; Kimmel S Postgrad Med; 1998 Jan; 103(1):133-8, 140. PubMed ID: 9448679 [TBL] [Abstract][Full Text] [Related]
19. [Hemodynamic changes during head-up tilt test and predictive value thereof in predicting the efficacy of metoprolol therapy in children with vasovagal syncope]. Zhang QY; DU JB; Zhen JL; Li WZ; Wang YL Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1260-2. PubMed ID: 17686261 [TBL] [Abstract][Full Text] [Related]
20. Comparison of diagnostic accuracy of sublingual nitroglycerin test and low-dose isoproterenol test in patients with unexplained syncope. Raviele A; Giada F; Brignole M; Menozzi C; Marangoni E; Manzillo GF; Alboni P Am J Cardiol; 2000 May; 85(10):1194-8. PubMed ID: 10802000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]